Home
About
Media
Contact

Home
About
Media
Contact

Rexahn Pharmaceuticals Announces Publication of Preclinical Data for Novel Anti-Cancer Compound RX-3117

October 1, 2013

InFinance, Videos

Rexahn Pharmaceuticals Announces Publication of Preclinical Data for Novel Anti-Cancer Compound RX-3117

0Shares

About the author

admin

Leave a Reply Cancel Reply

Save my name, email, and website in this browser for the next time I comment.

Contact

Corporate Profile LLC
1185 Ave of the Americas 3rd Floor
New York, NY 10036
(212) 931-8787

Copyright © Corporate Profile^®. All Rights Reserved. Disclaimer